Development of wireless multi-parameter monitoring system for viruses and very slow growing microorganisms

Biophage Pharma signs collaborates with National Taiwan University

26-Jul-2005

Biophage Pharma and the Institute of Biomedical Engineering of the NTU (National Taiwan University) announced the signing of a collaborative agreement aimed at accelerating the development and applications of novel nanotechnology-based biosensors for the detection of slow growing microorganisms and viruses.

Combining the unique properties of Surface Plasmon Resonance (SPR), gold nanoparticles and phages (or antibodies), this wireless multi-parameter monitoring system will be mainly used for the detection and quantification of viruses and very slow growing microorganisms like Mycobacterium tuberculosis.

Established in 1928, the National Taiwan University is the most prestigious and first integrated institution of higher education in Taiwan. "We are very proud to work with such a prestigious university and a high profile team. This M.O.U. marks a new and very exciting development in our portfolio of products extending our capabilities and adding a novel element to our detection products", said Dr. Mandeville, President and Chief Executive Officer. "The detection of very slowly growing bacteria such as Mycobacterium (7 to 10 days for tuberculosis) and also viruses are presently difficult with our impedance-based biosensor. The use of SPR and phages (or antibodies) will solved this difficulty and is, therefore, a perfect fit with the portfolio of products we are developing", added Dr. Mandeville.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances

See the theme worlds for related content

Topic world Antibodies

Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous

View topic world
Topic world Antibodies

Topic world Antibodies

Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous